Noda Y, Kido J, Sawada T, Tanaka K, Kumeda K, Yoshida S
JBMR Plus. 2025; 9(3):ziae172.
PMID: 39925621
PMC: 11803525.
DOI: 10.1093/jbmrpl/ziae172.
Cinque L, Pugliese F, Salcuni A, Trombetta D, Battista C, Biagini T
Front Endocrinol (Lausanne). 2023; 14:1205977.
PMID: 37600704
PMC: 10433156.
DOI: 10.3389/fendo.2023.1205977.
Pyromali I, Richard L, Derouault P, Vallat J, Ghorab K, Magdelaine C
Biomedicines. 2023; 11(6).
PMID: 37371660
PMC: 10295399.
DOI: 10.3390/biomedicines11061565.
Glotov O, Savostyanov K, Nagornova T, Chernov A, Fedyakov M, Raspopova A
Int J Mol Sci. 2022; 23(21).
PMID: 36361766
PMC: 9654387.
DOI: 10.3390/ijms232112976.
Shore R
Pediatr Radiol. 2022; 52(12):2278-2289.
PMID: 35536415
DOI: 10.1007/s00247-022-05374-y.
Young woman with hypophosphatasia: A case report.
Siami H, Parsamanesh N, Besharati Kivi S
Clin Case Rep. 2022; 10(3):e05633.
PMID: 35356190
PMC: 8958189.
DOI: 10.1002/ccr3.5633.
New structural variations responsible for Charcot-Marie-Tooth disease: The first two large deletions detected by CovCopCan software.
Pyromali I, Perani A, Nizou A, Benslimane N, Derouault P, Bourthoumieu S
Comput Struct Biotechnol J. 2021; 19:4265-4272.
PMID: 34429846
PMC: 8355829.
DOI: 10.1016/j.csbj.2021.07.037.
TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism.
Graser S, Liedtke D, Jakob F
Int J Mol Sci. 2021; 22(2).
PMID: 33477631
PMC: 7831495.
DOI: 10.3390/ijms22020919.
Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.
Jandl N, Schmidt T, Rolvien T, Sturznickel J, Chrysostomou K, von Vopelius E
Calcif Tissue Int. 2020; 108(3):288-301.
PMID: 33191482
PMC: 7881968.
DOI: 10.1007/s00223-020-00771-7.
Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia.
Del Angel G, Reynders J, Negron C, Steinbrecher T, Mornet E
Hum Mutat. 2020; 41(7):1250-1262.
PMID: 32160374
PMC: 7317754.
DOI: 10.1002/humu.24010.
Genetic analysis of adults heterozygous for ALPL mutations.
Taillandier A, Domingues C, Dufour A, Debiais F, Guggenbuhl P, Roux C
J Bone Miner Metab. 2017; 36(6):723-733.
PMID: 29236161
DOI: 10.1007/s00774-017-0888-6.
Genetic evaluations of Chinese patients with odontohypophosphatasia resulting from heterozygosity for mutations in the tissue-non-specific alkaline phosphatase gene.
Wan J, Zhang L, Liu T, Wang Y
Oncotarget. 2017; 8(31):51569-51577.
PMID: 28881669
PMC: 5584270.
DOI: 10.18632/oncotarget.18093.
Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.
Seefried L, Baumann J, Hemsley S, Hofmann C, Kunstmann E, Kiese B
J Clin Invest. 2017; 127(6):2148-2158.
PMID: 28436937
PMC: 5451251.
DOI: 10.1172/JCI83731.
Hypophosphatasia: an overview of the disease and its treatment.
Bianchi M
Osteoporos Int. 2015; 26(12):2743-57.
PMID: 26245849
DOI: 10.1007/s00198-015-3272-1.
Clinical utility gene card for: hypophosphatasia - update 2013.
Mornet E, Hofmann C, Bloch-Zupan A, Girschick H, Le Merrer M
Eur J Hum Genet. 2013; 22(4).
PMID: 23921539
PMC: 3953904.
DOI: 10.1038/ejhg.2013.177.
Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density.
Nielson C, Zmuda J, Carlos A, Wagoner W, Larson E, Orwoll E
J Bone Miner Res. 2011; 27(1):93-103.
PMID: 21956185
PMC: 3810303.
DOI: 10.1002/jbmr.527.
Clinical utility gene card for: hypophosphatasia.
Mornet E, Beck C, Bloch-Zupan A, Girschick H, Le Merrer M
Eur J Hum Genet. 2010; 19(3).
PMID: 20978533
PMC: 3061990.
DOI: 10.1038/ejhg.2010.170.
Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.
Fauvert D, Brun-Heath I, Lia-Baldini A, Bellazi L, Taillandier A, Serre J
BMC Med Genet. 2009; 10:51.
PMID: 19500388
PMC: 2702372.
DOI: 10.1186/1471-2350-10-51.